Technical Analysis for SURF - Surface Oncology, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| Historical SURF trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 4.39% | |
| Pocket Pivot | Bullish Swing Setup | 4.39% | |
| Bollinger Band Squeeze | Range Contraction | 4.39% | |
| Stochastic Reached Overbought | Strength | 4.39% | |
| Weak + Overbought | Other | 4.39% | |
| Overbought Stochastic | Strength | 4.39% | |
| Crossed Above 20 DMA | Bullish | 8.14% | |
| Pocket Pivot | Bullish Swing Setup | 8.14% | |
| Bollinger Band Squeeze | Range Contraction | 8.14% | |
| BB Squeeze Started | Range Contraction | 8.14% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 50 DMA Resistance | about 1 hour ago |
| Possible Pocket Pivot | about 2 hours ago |
| Up 1 ATR | about 2 hours ago |
| Rose Above 50 DMA | about 3 hours ago |
| 10 DMA Support | about 3 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
Surface Oncology is a clinical-stage immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment with lead programs targeting CD47 and CD73. Surface’s novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response, alone or in combination with other therapies. The company has a pipeline of immunotherapies and a strategic collaboration with Novartis focused on up to three next-generation cancer immunotherapies.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunotherapy Cancer Immunotherapy Cancer Treatments Virotherapy Tumor Immunotherapies Novel Cancer Cancer Research Cd73 CD47 Active Immunotherapy Tumor Microenvironment
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunotherapy Cancer Immunotherapy Cancer Treatments Virotherapy Tumor Immunotherapies Novel Cancer Cancer Research Cd73 CD47 Active Immunotherapy Tumor Microenvironment
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.38 |
| 52 Week Low | 2.4 |
| Average Volume | 1,566,503 |
| 200-Day Moving Average | 8.29 |
| 50-Day Moving Average | 7.90 |
| 20-Day Moving Average | 7.15 |
| 10-Day Moving Average | 7.28 |
| Average True Range | 0.53 |
| ADX | 18.62 |
| +DI | 16.96 |
| -DI | 19.44 |
| Chandelier Exit (Long, 3 ATRs ) | 6.76 |
| Chandelier Exit (Short, 3 ATRs ) | 7.85 |
| Upper Bollinger Band | 7.84 |
| Lower Bollinger Band | 6.45 |
| Percent B (%b) | 0.76 |
| BandWidth | 19.50 |
| MACD Line | -0.20 |
| MACD Signal Line | -0.31 |
| MACD Histogram | 0.1061 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.35 | ||||
| Resistance 3 (R3) | 8.26 | 7.89 | 8.21 | ||
| Resistance 2 (R2) | 7.89 | 7.68 | 7.94 | 8.16 | |
| Resistance 1 (R1) | 7.70 | 7.54 | 7.80 | 7.79 | 8.12 |
| Pivot Point | 7.33 | 7.33 | 7.38 | 7.38 | 7.33 |
| Support 1 (S1) | 7.14 | 7.12 | 7.24 | 7.23 | 6.90 |
| Support 2 (S2) | 6.77 | 6.98 | 6.82 | 6.86 | |
| Support 3 (S3) | 6.58 | 6.77 | 6.81 | ||
| Support 4 (S4) | 6.67 |
